The Next Era

in Drug Discovery

Picture of a Nextera employee holding a petri-dish with a culture of an undisclosed substance

Nextera is a drug and target discovery company

We are offering a unique and novel approach for improved therapeutic intervention in the major disease areas autoimmunity, chronic inflammatory disorders and cancer

Our approach is to modulate the disease at the core of the escalating immune cascade translating to disease-specific treatment without compromising systemic immunity

About us

Nextera is spun out from a world class Centre of Excellence research environment at the University of Oslo and Oslo University Hospital

Nextera employee holding a petri dish between two fingers.

Our technology

NextCore mimics the pivotal interaction between Antigen Presenting Cells (APC) and T helper cells (Th)

Enabling medicines of tomorrow by targeting the core of disease initiation